JAN RASNAKE: Open Payments
NPI 1356651897 · WYTHEVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 50 payments from 20 companies in 2025. Trend: 2023 $1,107 · 2024 $1,503 · 2025 $918
Food & beverage: $918
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $168 |
| Collegium Pharmaceutical, Inc. | 6 | $118 |
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| ABBVIE INC. | 4 | $72 |
| PFIZER INC. | 3 | $45 |
| Inspire Medical Systems, Inc. | 1 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Dexcom, Inc. | 1 | $32 |
| Insulet Corporation | 1 | $31 |
Products named: Jornay PM, CAPLYTA, Ozempic, AIRSUPRA, NURTEC ODT, INSPIRE, UBRELVY, AUSTEDO XR.
Industry payments across VA — which companies pay providers there.
